These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 28187493

  • 1. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E, Allard MA, Selten J, Golse N, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Adam R.
    Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
    [Abstract] [Full Text] [Related]

  • 2. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S, Hyuck David Kwon C, Man Kim J, Joh JW, Woon Paik S, Kim BW, Wang HJ, Lee KW, Suh KS, Lee SK.
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [Abstract] [Full Text] [Related]

  • 3. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G, Goldaracena N, Astete S, Laurence JM, Davidson D, Rafael E, Castells L, Sandroussi C, Bilbao I, Dopazo C, Grant DR, Lázaro JL, Caralt M, Ghanekar A, McGilvray ID, Lilly L, Cattral MS, Selzner M, Charco R, Greig PD.
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [Abstract] [Full Text] [Related]

  • 4. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW.
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P, Li H, Shi B, Que W, Wang C, Fan J, Peng Z, Zhong L.
    Oncotarget; 2016 Jun 07; 7(23):35071-83. PubMed ID: 27145461
    [Abstract] [Full Text] [Related]

  • 6. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
    Piñero F, Marciano S, Anders M, Orozco Ganem F, Zerega A, Cagliani J, Andriani O, de Santibañes E, Gil O, Podestá LG, McCormack L, Gadano A, Silva M.
    Eur J Gastroenterol Hepatol; 2016 Apr 07; 28(4):421-7. PubMed ID: 26684693
    [Abstract] [Full Text] [Related]

  • 7. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.
    Liu B, Teng F, Fu H, Guo WY, Shi XM, Ni ZJ, Gao XG, Ma J, Fu ZR, Ding GS.
    BMC Gastroenterol; 2015 Oct 15; 15():138. PubMed ID: 26472203
    [Abstract] [Full Text] [Related]

  • 8. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.
    Transplant Proc; 2011 Dec 15; 43(10):3813-8. PubMed ID: 22172852
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY, Suh KS, Lee HW, Kim J, Kim T, Yi NJ, Lee KU.
    Liver Transpl; 2010 May 15; 16(5):678-84. PubMed ID: 20440777
    [Abstract] [Full Text] [Related]

  • 10. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure?
    De Carlis L, Di Sandro S, Giacomoni A, Mangoni I, Lauterio A, Mihaylov P, Cusumano C, Rampoldi A.
    J Clin Gastroenterol; 2013 Apr 15; 47(4):352-8. PubMed ID: 23188072
    [Abstract] [Full Text] [Related]

  • 11. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H.
    Ann Surg; 2003 Oct 15; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [Abstract] [Full Text] [Related]

  • 12. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.
    Aramaki M, Kawano K, Kai T, Yokoyama H, Morii Y, Sasaki A, Yoshida T, Kitano S.
    Hepatogastroenterology; 1999 Oct 15; 46(29):2931-4. PubMed ID: 10576375
    [Abstract] [Full Text] [Related]

  • 13. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q, Deng YL, Liu C, Huang LH, Shang L, Chen XG, Wang LT, Du JZ, Wang Y, Wang PX, Zhang H, Shen ZY.
    World J Gastroenterol; 2016 Nov 21; 22(43):9571-9585. PubMed ID: 27920478
    [Abstract] [Full Text] [Related]

  • 14. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
    Lai Q, Inostroza M, Rico Juri JM, Goffette P, Lerut J.
    HPB (Oxford); 2015 Dec 21; 17(12):1085-95. PubMed ID: 26373980
    [Abstract] [Full Text] [Related]

  • 15. Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story.
    Halazun KJ, Najjar M, Abdelmessih RM, Samstein B, Griesemer AD, Guarrera JV, Kato T, Verna EC, Emond JC, Brown RS.
    Ann Surg; 2017 Mar 21; 265(3):557-564. PubMed ID: 27611615
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y.
    Transplantation; 2013 Dec 15; 96(11):1008-12. PubMed ID: 24113512
    [Abstract] [Full Text] [Related]

  • 17. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
    Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY.
    Liver Transpl; 2014 Aug 15; 20(8):945-51. PubMed ID: 24797281
    [Abstract] [Full Text] [Related]

  • 18. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
    Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J.
    Cancer; 2000 Aug 01; 89(3):500-7. PubMed ID: 10931448
    [Abstract] [Full Text] [Related]

  • 19. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
    Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.
    Hepatobiliary Pancreat Dis Int; 2012 Jun 01; 11(3):256-61. PubMed ID: 22672818
    [Abstract] [Full Text] [Related]

  • 20. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC, Chan SC, Chok KS, Cheung TT, Chiu DW, Poon RT, Fan ST, Lo CM.
    Liver Transpl; 2013 Apr 01; 19(4):411-9. PubMed ID: 23447460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.